Fahim Farzadfard

Fahim Farzadfard has a wealth of experience in research and technology. Fahim began their career in 2007 as a Researcher at DTU - Technical University of Denmark. In 2008, they moved to Chalmers University of Technology as a Researcher. In 2010, they joined the Massachusetts Institute of Technology as a Postdoctoral Fellow and Graduate Research Assistant. In 2018, they became a Postdoctoral Researcher at Harvard Medical School. Most recently, in 2020, they founded and became CTO of March Therapeutics, Inc.

Fahim Farzadfard obtained their Bachelor of Science in Biotechnology from the University of Tehran in 2007. Fahim then went on to receive their Master of Science in Molecular Biotechnology from the same university in 2010. Finally, Fahim Farzadfard completed their Ph.D. in Synthetic Biology from the Massachusetts Institute of Technology in 2018.